logo
15:58 Jun 25

Divi's Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
6713.50
-40.00 (-0.59%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Divi's Laboratories Ltd. Financials

Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
6713.50
-40.00 (-0.59%)
15:58 Jun 25
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

25/100
Expensive Valuation

Technical

65/100
Technically Moderately Bullish

Strength

12

Weakness

4

Opportunity

1

Threats

1

15.32 %

ROE %

12.81 %

ROA %

96.73

EPS

632.49

BVPS

24.31 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
8959.83 7767.51 7845 9360 10560
Operating Expenses +
5077.89 5399.69 5640 6392 7119
Raw Material
3490.97 3030.69 3238 3821 4378
Increase Decrease in Cost
-523.83 23.03 -109 -96 -285
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
946.16 975.02 1094 1243 1442
Miscellaneous Expenses
1193.41 1415.61 1429 1424 1584
Operating Profit
3881.94 2367.82 2205 2968 3441
Other Income
113.87 344.66 339 352 507
Depreciation
311.51 343.18 378 402 463
Interest
0.8 0.67 3 2 23
Profit before tax and exceptio..
3683.5 2368.63 2163 2916 3462
Exceptional Items
0 0 0 0 -74
PBT
3683.5 2368.63 2163 2916 3388
Provision for Taxation
723.05 545.25 563 725 820
Net Profit
2960.45 1823.38 1600 2191 2568
NET Profit after MI
2960.45 1823.38 1600 2191 2568
EPS
111.52 68.69 60.27 82.53 96.75
Operating Profit Margin (%)
43.33 30.48 28.11 31.71 32.59
Net Profit Margin (%)
33.04 23.47 20.4 23.41 24.32

Divi's Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: